Legal & General Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4M Buy
663,595
+89,958
+16% +$1.95M ﹤0.01% 996
2025
Q1
$13.9M Buy
573,637
+229,014
+66% +$5.55M ﹤0.01% 969
2024
Q4
$7.19M Buy
344,623
+18,177
+6% +$379K ﹤0.01% 1373
2024
Q3
$6.49M Buy
326,446
+21,002
+7% +$418K ﹤0.01% 1447
2024
Q2
$4.73M Sell
305,444
-4,047
-1% -$62.7K ﹤0.01% 1556
2024
Q1
$4.93M Buy
309,491
+21,676
+8% +$346K ﹤0.01% 1523
2023
Q4
$4.84M Sell
287,815
-445
-0.2% -$7.48K ﹤0.01% 1517
2023
Q3
$3.37M Buy
288,260
+7,092
+3% +$82.9K ﹤0.01% 1657
2023
Q2
$3.78M Buy
281,168
+41,580
+17% +$559K ﹤0.01% 1612
2023
Q1
$3.97M Sell
239,588
-385
-0.2% -$6.38K ﹤0.01% 1539
2022
Q4
$4.46M Buy
239,973
+13,448
+6% +$250K ﹤0.01% 1460
2022
Q3
$2.91M Buy
226,525
+188,774
+500% +$2.42M ﹤0.01% 1663
2022
Q2
$265K Buy
37,751
+2,917
+8% +$20.5K ﹤0.01% 2536
2022
Q1
$289K Hold
34,834
﹤0.01% 2547
2021
Q4
$236K Hold
34,834
﹤0.01% 2656
2021
Q3
$185K Buy
34,834
+19,493
+127% +$104K ﹤0.01% 2717
2021
Q2
$88K Sell
15,341
-9,283
-38% -$53.3K ﹤0.01% 2778
2021
Q1
$114K Buy
24,624
+10,857
+79% +$50.3K ﹤0.01% 2584
2020
Q4
$46K Hold
13,767
﹤0.01% 2823
2020
Q3
$41K Sell
13,767
-4,289
-24% -$12.8K ﹤0.01% 2754
2020
Q2
$84K Buy
18,056
+834
+5% +$3.88K ﹤0.01% 2575
2020
Q1
$66K Sell
17,222
-4,335
-20% -$16.6K ﹤0.01% 2519
2019
Q4
$81K Sell
21,557
-1,371
-6% -$5.15K ﹤0.01% 2661
2019
Q3
$121K Sell
22,928
-1,260
-5% -$6.65K ﹤0.01% 2468
2019
Q2
$93K Buy
24,188
+9,450
+64% +$36.3K ﹤0.01% 2556
2019
Q1
$75K Hold
14,738
﹤0.01% 2578
2018
Q4
$28K Hold
14,738
﹤0.01% 2932
2018
Q3
$56K Hold
14,738
﹤0.01% 2715
2018
Q2
$46K Sell
14,738
-686
-4% -$2.14K ﹤0.01% 2785
2018
Q1
$37K Sell
15,424
-1,645
-10% -$3.95K ﹤0.01% 2890
2017
Q4
$68K Buy
17,069
+6,467
+61% +$25.8K ﹤0.01% 2757
2017
Q3
$27K Hold
10,602
﹤0.01% 3086
2017
Q2
$29K Buy
+10,602
New +$29K ﹤0.01% 3047
2016
Q2
Sell
-10,410
Closed -$12K 2911
2016
Q1
$12K Hold
10,410
﹤0.01% 2729
2015
Q4
$26K Hold
10,410
﹤0.01% 2668
2015
Q3
$31K Buy
+10,410
New +$31K ﹤0.01% 2635